PCP-3R
Triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. Developed for metabolic research, it represents the next generation of weight management compounds. Studies show significant effects on appetite regulation, glucose metabolism, and fat reduction. One of the most potent multi-receptor peptides in current research.
Reviews
There are no reviews yet.